XML 29 R16.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Stockholders' Deficit | 6 Months Ended
--- | ---
Jun. 30, 2024
Stockholders' Deficit |
Stockholders' Deficit | 10. Stockholders’ Deficit Public Offering On May 16, 2023, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with J.P. Morgan Securities LLC and Citigroup Global Markets Inc., as representatives of the several underwriters named therein (collectively, the “Underwriters”), pursuant to which the Company issued and sold an aggregate of 11,764,706 shares (the “Firm Shares”) of its common stock, par value $0.0001 per share, to the Underwriters (the “Public Offering”). Additionally, under the terms of the Underwriting Agreement, the Company granted the Underwriters an option, for 30 days from the date of the Underwriting Agreement, to purchase up to an additional 1,764,705 shares of common stock (the “Option Shares,” and together with the Firm Shares, the “Shares”), which the Underwriters elected to exercise in full. The price to the public in the Public Offering was $4.25 per share. The Underwriters agreed to purchase the Shares from the Company pursuant to the Underwriting Agreement at a price of $3.995 per share. The Offering was made pursuant to a prospectus supplement and related prospectus filed with the SEC pursuant to the Company’s shelf registration statement on Form S-3 that was declared effective on November 17, 2022 (the “Registration Statement”) under which the Company may offer and sell up to $150.0 million in the aggregate of its common stock, preferred stock, debt securities, warrants and units from time to time in one or more offerings. On May 18, 2023, the Company completed the sale and issuance of an aggregate of 13,529,411 Shares, including the exercise in full of the Underwriters’ option to purchase the Option Shares. The Company received net proceeds of approximately $53.6 million, after deducting the Underwriters’ discounts and commissions and offering expenses payable by the Company. ATM Offering On November 8, 2022, the Company filed the Registration Statement. Also on November 8, 2022, the Company entered into a sales agreement (“Sales Agreement”) with Cowen and Company, LLC (“TD Cowen”), pursuant to which the Company may issue and sell from time to time up to $150.0 million of its common stock through or to TD Cowen as the Company’s sales agent or principal in an at-the-market offering (“ATM Offering”). On May 15, 2023, pursuant to an Amendment No. 1 to Sales Agreement and in connection with the Public Offering, the Company reduced the amount of shares that could be issued and sold pursuant to its ATM Offering with TD Cowen by $86.2 million, lowering the aggregate offering price under the Sales Agreement from $150.0 million to $63.8 million. On September 11, 2023, pursuant to an Amendment No. 2 to Sales Agreement, the Company increased the amount of shares that could be issued and sold pursuant to its ATM Offering with TD Cowen by $28.7 million, increasing the aggregate offering price under the Sales Agreement from $63.8 million to $92.5 million. There were no shares sold under the ATM Offering during the three months ended June 30, 2024 and 2023. The following table summarizes information regarding settlements under the ATM Offering for the six months ended June 30, 2024 and 2023: ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Six Months Ended June 30,
(in thousands, except share and per share data) | ​ | 2024 |  | 2023
Number of common stock shares sold during the period | ​ | ​ | 650,005 | ​ | ​ | 1,131,450
Weighted-average price per share | ​ | $ | 2.44 | ​ | $ | 6.54
Gross proceeds | ​ | $ | 1,589 | ​ | $ | 7,401
Less commissions and fees | ​ |  | (40) | ​ |  | (185)
Net proceeds after commissions and fees | ​ | $ | 1,549 | ​ | $ | 7,216
​ As of June 30, 2024, the Company had approximately $64.9 million of its common stock remaining available for sales under the ATM Offering. ​ ​

X
- Definition Disclosure containing information regarding Stockholders' Deficit. + References No definition available. + Details
Name: | chrs_StockholdersDeficitTextBlock
Namespace Prefix: | chrs_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration